Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

A Study of the Long-term Safety of ABT-089 for Subjects With Mild-to-moderate Alzheimer's Disease Who Participated in the M06-876 Study

ClinicalTrials.gov ID: NCT00809510

Public ClinicalTrials.gov record NCT00809510. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 12:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to evaluate the long-term safety and tolerability of ABT-089 in adults with mild-to-moderate Alzheimer's disease.

Study identification

NCT ID
NCT00809510
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Abbott
Industry
Enrollment
63 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
55 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2008
Primary completion
May 31, 2009
Completion
Not listed
Last update posted
Sep 1, 2011

Started 2009

United States locations

U.S. sites
22
U.S. states
11
U.S. cities
22
Facility City State ZIP Site status
Site Reference ID/Investigator# 16543 Phoenix Arizona 85006
Site Reference ID/Investigator# 16528 Sun City Arizona 85351
Site Reference ID/Investigator# 16524 Fresno California 93720
Site Reference ID/Investigator# 16520 San Diego California 92108
Site Reference ID/Investigator# 16521 Santa Monica California 90404
Site Reference ID/Investigator# 16533 Hamden Connecticut 06518
Site Reference ID/Investigator# 16516 Brooksville Florida 34601
Site Reference ID/Investigator# 16510 Deerfield Beach Florida 33064
Site Reference ID/Investigator# 16508 Delray Beach Florida 33445
Site Reference ID/Investigator# 16515 Miami Florida 33180
Site Reference ID/Investigator# 16545 Palm Beach Gardens Florida 33418
Site Reference ID/Investigator# 16541 Sunrise Florida 33351
Site Reference ID/Investigator# 16542 Tampa Florida 33613
Site Reference ID/Investigator# 16529 West Palm Beach Florida 33407
Site Reference ID/Investigator# 16526 Indianapolis Indiana 46260
Site Reference ID/Investigator# 16527 Eatontown New Jersey 07724
Site Reference ID/Investigator# 16523 Ridgewood New Jersey 07450
Site Reference ID/Investigator# 16532 New York New York 10021
Site Reference ID/Investigator# 16519 Winston-Salem North Carolina 27103
Site Reference ID/Investigator# 16525 Centerville Ohio 45459
Site Reference ID/Investigator# 16507 Wichita Falls Texas 76309
Site Reference ID/Investigator# 16509 Bennington Vermont 05201

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00809510, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 1, 2011 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00809510 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →